Medical Technology & Services

Innovative Development, Shifting Regulatory Landscape, Vast Growth Potential.

Healthcare related spending accounted for more than 18% of the US GDP in 2018, roughly $3.65 trillion, and that number is on the rise. New science and technology, an aging populace, and a changing regulatory environment are combining to present incredible growth opportunities for small and middle-market companies in medical products and services – driving dynamic M&A activity.   

Accelerating competitive pressure and access to significant amounts of capital have led to an increase in specialization, partnering, and outsourcing rather than vertical integration—making deals in this sector more complicated and creating greater emphasis on a more expansive and detailed due diligence process.

Many investment banking and advisory firms specialize in subsectors of the Medical Technology & Services industry, but Dunn Rush & Co. brings key insights to the M&A process for privately held, family-owned middle-market companies that our competitors don’t. Our partners and managing directors have gone through exactly what you’re going through now—as CEOs, CTOs, and CFOs of middle-market companies in the Medical Technology & Services sector. We know what questions to ask, pitfalls to avoid, and how to identify the critical savings and synergies that need to be communicated effectively to buyers in order to achieve the maximum value and optimal outcome for you and your company.


Some of Our Past Deal Sub-Sector Specialities include:

      • Analytical Tools
      • Clinical Research Organizations
      • Diagnostics
      • Healthcare Information Technology
      • Healthcare Services
      • Home Healthcare Services
      • Imaging
      • Lab Consumables
      • Lab Services
      • Medical Devices
      • Wellness Devices

Selected Recent Transactions

has been acquired by

Financial Advisory Recapitalization

has been acquired by

View All Transactions

What Clients Are Saying About Dunn Rush

I have seen the Dunn Rush team perform in several sell-side situations. You want them on your team! Their preparation and attention to detail is impressive. They are also real good people to have by your side during a stressful time. In the case of Bridgeport Fittings, Kevin and Greg introduced us to their Gold Standard of Preparation and we took their advice getting audited financial statements and a Quality of Earnings report. This preparation made the due diligence process go smoothly, helped the firm proactively address issues and greatly improved the due diligence process. The final results exceeded our expectations.

Ted Patton / Managing Director, Hastings Equity Partners.

I’ve known the Principals of Dunn Rush & Co., for a number of years and have had the opportunity to work with them in many different capacities. They’re true professionals, with deep experience in a wide range of transactions, across several industries. They are good people and I have always enjoyed working with them. You can trust them to provide top-quality advice no matter what your situation or circumstances.



Mark Bono / Founder, Guide Capital Partners

When I decided to sell my third generation, family business, I had many concerns. I wanted to be represented by an Investment Bank who had a strong reputation in the mergers and acquisition market, knew the market we participated in well enough to target likely interested parties, and who would manage the process of the transaction with various family members with various personal interests.



Betsy Alden / Former CEO and Owner, Alden Products

In my 40 plus years on Wall Street, I have met regiments of investment bankers. There have been none – i.e., not one – with the combined talent and integrity of Kevin Dunn.

John Adams / Founder, Adams Harkness & Hill and Chairman, Canaccord Adams (US)

Want to find out more? Get in touch.